Status:

RECRUITING

Congenital Heart Disease Physical Activity Lifestyle Study V.2

Lead Sponsor:

Jamie Jackson

Collaborating Sponsors:

National Institute of Nursing Research (NINR)

Conditions:

Heart Defects, Congenital

Cardiovascular Disease Other

Eligibility:

All Genders

15-25 years

Phase:

NA

Brief Summary

The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) w...

Detailed Description

Current estimates indicate more than 2 million individuals in the United States have CHD. CHD survivors are now living well into adulthood, including those with moderate and complex forms of CHD, who ...

Eligibility Criteria

Inclusion

  • Between the ages of 15-25 years
  • Diagnosed with moderate or complex structural CHD
  • Actively receiving care from a cardiologist at Nationwide Children's Hospital (NCH) or Ohio State University (OSU)

Exclusion

  • Unable to speak and read proficiently in English
  • Have a diagnosis of a genetic syndrome that impacts multiple organ systems
  • Have cognitive impairments that would interfere with completing study measures
  • Have been engaged in a formal exercise program within the past 6 months,
  • Have participated in the intervention arm of the previous CHD-PAL Study
  • Have undergone open-heart surgery or had a valve replacement in the last 3 months
  • Are unable to complete an exercise stress test using a treadmill
  • Are pregnant
  • Are prohibited to engage in at least moderate levels of physical activity by their cardiologist
  • Engage in \>30 minutes of moderate-to-vigorous physical activity per day, on average per accelerometer
  • Have contraindications for exercise based on an exercise stress test (e.g., exercise-induced arrhythmias or evidence of cardiac ischemia)

Key Trial Info

Start Date :

July 18 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2027

Estimated Enrollment :

144 Patients enrolled

Trial Details

Trial ID

NCT06003023

Start Date

July 18 2023

End Date

June 30 2027

Last Update

April 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nationwide Children's Hospital

Columbus, Ohio, United States, 43205